U.S. Markets close in 2 hrs 3 mins

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
8.73+0.05 (+0.58%)
As of 4:00PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.47
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 313.30
52 Week Low 38.24
50-Day Moving Average 39.35
200-Day Moving Average 310.13

Share Statistics

Avg Vol (3 month) 38.82M
Avg Vol (10 day) 39.62M
Shares Outstanding 51.1B
Implied Shares Outstanding 6N/A
Float 81.1B
% Held by Insiders 11.05%
% Held by Institutions 152.24%
Shares Short (Jun 14, 2021) 435.57M
Short Ratio (Jun 14, 2021) 45.02
Short % of Float (Jun 14, 2021) 4N/A
Short % of Shares Outstanding (Jun 14, 2021) 43.24%
Shares Short (prior month May 13, 2021) 435.5M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 11, 2017
Ex-Dividend Date 4Nov 26, 2017
Last Split Factor 22:1
Last Split Date 3Jun 30, 2004

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin -24.45%
Operating Margin (ttm)17.61%

Management Effectiveness

Return on Assets (ttm)3.44%
Return on Equity (ttm)-31.61%

Income Statement

Revenue (ttm)16.28B
Revenue Per Share (ttm)14.85
Quarterly Revenue Growth (yoy)-8.60%
Gross Profit (ttm)7.73B
Net Income Avi to Common (ttm)-3.98B
Diluted EPS (ttm)-3.63
Quarterly Earnings Growth (yoy)11.60%

Balance Sheet

Total Cash (mrq)1.74B
Total Cash Per Share (mrq)1.58
Total Debt (mrq)25.43B
Total Debt/Equity (mrq)231.67
Current Ratio (mrq)1.03
Book Value Per Share (mrq)9.07

Cash Flow Statement

Operating Cash Flow (ttm)506M
Levered Free Cash Flow (ttm)1.38B